Hyperbaric Oxygen: A Safe & Successful Treatment for Retinal Artery Occlusion

5 patients were followed after receiving HBOT for Retinal Artery Occlusion. All patients improved and there were no complications to the treatment <view study>

Mild hyperbaric therapy delays diabetes-induced cataracts

Hyperbaric oxygen therapy is widely used for a variety of diabetes-induced conditions, particularly, but not limited, to wound healing. Its effects on diabetes-induced cataracts is still unclear. A study published in late 2001 in the Journal of Diabetes has given some new insights. They used lower pressures (1.25 ATA) and found that this dosage was able to delay both the development and the progression of diabetes-induced cataracts. <view study>

Plastic Surgery gone wrong — Hyperbaric oxygen to the rescue!

Cosmetic treatments like facial fillers are gaining popularity, but not without risks. One of the more serious complications following this cosmetic procedure is blindness. A case report was presented where HBOT was applied for 14 days, causing visual acuity to return back to normal. The clinical implications of this study are massive for certain groups of individuals who are at greater risk for blindness following facial fillers <view study>

Hyperbaric oxygen therapy reverses vision loss

A 26 year old male presented with sudden vision loss. After just 2 weeks of hyperbaric oxygen therapy, his visual acuity returned to normal <view study>

The effects of hyperbaric oxygen therapy on diabetic retinopathy

Diabetic foot ulcers treated with a 30 session course of hyperbaric oxygen therapy (2.5 ATA per 90 minute session, 5 days per week) showed improvements in diabetic retinopathy lesions and a along with reductions in central macular thickness (CMT). <view study>

Hyperbaric Oxygen therapy helps improve mumps virus-induced Retinitis

This case report of a 4 year old boy demonstrated both improvement and recovery in vision after being diagnosed with mumps-induced retinits <view study>

Hyperbaric Oxygen Therapy for the treatment of Macular Degeneration

Age-Related Macular Degeneration (AMD) is a main cause of vision loss in North America and is expected to impact our society considerably as our aging population grows. This publication clearly demonstrates the value of HBOT as 14 patients with advanced AMD made significant improvements in vision following hyperbaric oxygenation therapy <view study>